Vaxcyte, Inc. ( PCVX) - Key Metrics
PCVX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.97 | -$3.55 | -$3.69 |
| 2026Q1 | $0 | -$2.30 | -$2.01 | -$2.12 |
| 2025Q4 | $0 | -$1.81 | -$1.65 | -$1.61 |
| 2025Q3 | $0 | -$1.56 | -$1.05 | -$1.14 |
| 2025Q2 | $0 | -$1.22 | -$0.89 | -$0.75 |
PCVX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -7.38 |
| 2026Q1 | 0% | -6.32 |
| 2025Q4 | 0% | -6.37 |
| 2025Q3 | 0% | -5.77 |
| 2025Q2 | 0% | -6.66 |
PCVX
Price: $67.72
52 week price:
Earnings Per Share: -7.75 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 346400
Market Capitalization: 8.2 billion